Which IL-1 Inhibitors are available?

This directory covers 2: Kineret, Ilaris.

IL-1 Inhibitors

Also called interleukin-1 blockers

IL-1 inhibitors block interleukin-1, a cytokine at the very top of the inflammatory cascade. They are the mainstay of the rare auto-inflammatory syndromes — conditions caused by an immune system that switches itself on without any infection to fight — and are also used in gout flares and certain forms of juvenile arthritis.

What this class is used for

Auto-inflammatory syndromes, rheumatoid arthritis, gout flares, Still's disease

2 IL-1 Inhibitors in this directory

Kineret

Anakinra

An injectable medication used to treat rheumatoid arthritis and neonatal-onset multisystem inflammatory disease.

Ilaris

Canakinumab

An injectable biological therapy used to treat periodic fever syndromes and Still's disease.

Browse other drug classes

ARBs Anti-amyloid Antibodies Antibiotics Antibody-drug Conjugates Anticoagulants Anticonvulsants Antihistamines Antiplatelets Asthma & COPD Inhalers Atypical Antipsychotics BTK Inhibitors Beta Blockers CD20 Antibodies CDK4/6 Inhibitors CGRP Inhibitors COVID-19 Antivirals Checkpoint Inhibitors Cholinesterase Inhibitors Complement Inhibitors DPP-4 Inhibitors EGFR Inhibitors Enzyme Replacement Therapy GLP-1 Agonists Gene & Cell Therapies HIV Antiretrovirals Hepatitis C Antivirals IL-17 Inhibitors IL-23 Inhibitors IL-5 Inhibitors IL-6 Inhibitors Insulins JAK Inhibitors PARP Inhibitors PCSK9 Inhibitors Proton Pump Inhibitors SGLT2 Inhibitors SSRIs & SNRIs Statins TNF Inhibitors TTR Silencers Tyrosine Kinase Inhibitors

Class descriptions are written by the Priya Life Science editorial team. Individual drug pages combine that summary with live label, approval, manufacturer and shortage data from the U.S. FDA via the openFDA API. This page is general information and is not medical advice — it is not exhaustive, drugs within a class are not automatically interchangeable, and approvals and brand names differ between the US, EU/Ireland (EMA/HPRA) and other regions. Always consult the official prescribing information and your clinician or pharmacist. Related: Drug Shortages Tracker · FDA Approvals · All drug comparisons